chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got a bumpy itchy rash on both legs which is still present; sweating; arm began to hurt then throb and go numb a bit; arm began to hurt then throb and go numb a bit; The patient was cold; clammy; the first blood pressure was 90 over something/second blood pressure was 70 over 40 something; diarrhea; tired; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: 3247), via an unspecified route of administration in the left arm on 18Jan2021 10:00 at a single dose for COVID-19 immunization. The patient's medical history was none. There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 18Jan2021 10:10, the patient's arm began to hurt then throb and go numb a bit. On 18Jan2021 10:15, the patient started sweating. She stood up to try and feel better. The patient's husband called the nurse over and they called the paramedics because they said the patient was cold, clammy, and still sweating. The patient sat down again and they put leads on me to check her heart rate, blood pressure (BP), and oxygen on 18Jan2021. Her heart rate and oxygen were fine but the first BP was 90 over something. A few minutes later, she closed her eyes and could have fallen asleep right there. Her second BP was 70 over 40 something. She opened up her eyes and tried to stand up again. After a few more minutes, her BP came up and was OK. They refused an ambulance and went home. She had diarrhea at home on 18Jan2021. She ate, walked and felt better. She just experienced the normal tired and hurt arm in the afternoon on 18Jan2021. She rested the balance of the day. On Wednesday (20Jan2021), she got a bumpy itchy rash on both legs which is still present but with cream, it was OK. No treatment was received for the adverse events. Outcome of the "the first blood pressure was 90 over something/second blood pressure was 70 over 40 something" was recovered on 18Jan2021 and of the remaining events was recovered on Jan2021.
flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.            No concomitant medication were reported.No treatment information was provided.Action taken with mRNA-1273 in response to the events was not applicable.
No further adverse event; Medical assistant reported while administering VARIVAX dose, the patient moved and did not receive a full dose; This spontaneous report was received from a registered medical assistant and refers to a 4 years and 7 months old patient of unknown gender. The patient's concurrent conditions, drug reaction or allergies, pertinent medical history and concomitant therapies were not reported.  On 30-AUG-2023, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) for prophylaxis (dose, lot #, expiration date and route were not reported). While administering of the vaccine, the patient moved and did not receive a full dose (incorrect dose administered).  No further adverse event and nor product quality complain were reported.
Left arm red, firm, and hot to touch. SS started on 05/04/05.
Patient complained of headache and loss of peripheral vision in left eye; recommended go to ER for evaluation as soon as possible
6/21  2 hrs after administration itching and swelling, slight fever per mother. 6/23/06 warm erythematous right upper outer arm, no fever. Keflex 250mg PO qid x 7 days/Benadryl.
Rash on the back of my neck the following night.  Persistent chest, rib and back pain on the left side ? abnormal ecg reading
2 days after administration, left medial arm itching and erythema that was different from localized swelling around injection site. Also itching, dryness, vesicular rash in bilateral lower legs that persists to today,  3 weeks later. No breathing difficulty or signs of anaphylaxis. Improving gradually. Will being trying topical corticosteroids and antihistamine.
This spontaneous report received from a health care worker refers to a patient of unknown demographics. No medical history was reported. On an unknown date, the patient was vaccinated with an improperly stored GARDASIL 9 (lot # L011846, expiry date: 16-JUN-2017, dose and route: unknown) and (Merck) VARIVAX (lot # L007224, expiry date: 03-MAR-2017, dose and route: unknown). No other concomitant therapy was reported. The outcome of the event was unknown. This case is linked to cases: # 1509USA011273 and # 1509USA011272. (same reporter link). Additional information has been requested.
Severe muscle aches since second injection. Lethargy, headaches, joint stiffness, nausea. At 13 days of continuous symptoms at time of reporting. Unsure if these are normal side effects for this long.
Case previously recorded as MA2009-6269. Initial case report received from a health care professional on 25 NOV 2009. Twenty children younger than 04 years of age received FLUVIRIN intramuscular inadvertent administration on an unknown date. No adverse events reported. Medical history: Not reported. Reference no. NA09-008851.
explosive onset of anxiety, OCD, germ-phobia, and increased facial tics.  negative rapid strep.  ASO titer pending.
pain in my arm; body hurts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Feb2021 12:15 (Lot number: EL-9809) at the age of 45 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Zithromax, reaction(s): "Allergies to medications, food, or other products:Zithomax"; Sulpha antibiotic, reaction(s): "Drug Allergy". Vaccination history included: Bnt162b2, administration date: Jan2021, when the patient was 45 years old, for Covid-19 immunization, reaction(s): "headache", "high my blood pressure 160/90 and later 180/90", "felt on my period", "small rash". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "pain in my arm"; PAIN (non-serious), outcome "unknown", described as "body hurts". The events "pain in my arm" and "body hurts" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not take any other medications the patient received within 2 weeks of vaccination. Patient was not diagnosed with COVID-19 prior to vaccination. Patient had not been tested for COVID-19 Since the vaccination. Patient received treatment for high blood pressure medication for two days. COVID-19 vaccine was administered at other facility.  No follow-up attempts are possible. No further information is expected.
About 5 minutes after administering vaccine I found patient sitting in chair experiencing a seizure and was unresponsive for a couple of minutes. Patient was pale and had perfuse sweating. After a couple of minutes patient was able to speak and was coherent. We called paramedics and they checked hi out in ambulance. Patient was released and was ok
Immediate test of strong metal in my mouth/ same strong metal taste/ following each shot iI tasted metal (strong taste); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Apr2021 10:00 (Lot number: ER8727) as dose 1, single and administered in arm right, administration date 05May2021 (Lot number: EW0171) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: DYSGEUSIA (non-serious) with onset 19Apr2021 10:00, outcome "recovered" (2021), described as "Immediate test of strong metal in my mouth/ same strong metal taste/ following each shot iI tasted metal (strong taste)". Therapeutic measures were not taken as a result of dysgeusia.  Additional information: Immediately following each shot I tasted metal (strong taste) it has since subsided gradually. No other reaction. The patient had no known allergies and other medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. Facility type of vaccine is Hospital. Vaccine was administered at Facility  No follow-up attempts are possible. No further information is expected.
Patient states got both vaccines in same arm, 8 hours later he presented with fever which rose to 104 degrees by the next morning. He went to the hospital where he was diagnosed with cellulitis and sepsis & was kept for 4 days for treatment.
p/vax pt devel severe h/a that are so bad had to go to bed to ease the pain;h/a sometimes lead to nausea & dizziness, loss of depth perception;
Initial unsolicited report received from a pharmacist (Director of Pharmacy) on 12 October 2016. This case is linked with 2016SA189772, 2016SA189781, 2016SA189791, 2016SA189792, 2016SA189793, 2016SA189794, 2016SA189795, 2016SA189796, 2016SA189797, 2016SA189798, 2016SA189799, 2016SA189800, 2016SA189801, 2016SA189802, 2016SA189803, 2016SA189804, 2016SA189805, 2016SA189806, 2016SA189807, 2016SA189808, 2016SA189809, 2016SA189810, 2016SA189811, 2016SA189812, 2016SA189813, 2016SA189814, 2016SA189815, 2016SA189816, 2016SA189817, 2016SA189818, 2016SA189819, 2016SA189820, 2016SA189821, 2016SA189822, 2016SA189823, 2016SA189824, 2016SA189825, 2016SA189827, 2016SA189828, 2016SA189829, 2016SA189830, 2016SA189831, 2016SA189832, 2016SA189833, 2016SA189834, 2016SA189835, 2016SA189836, 2016SA189837, 2016SA189838, 2016SA189839, 2016SA189840, 2016SA189842, 2016SA189843, 2016SA189844, 2016SA189845, 2016SA189846, 2016SA189847, 2016SA189848 (same vaccine). This case involves a patient of unknown age and gender, who was vaccinated with a dose of FLUZONE (batch number: UI669AA, expiry date: 30-JUN-2017 and site of administration was not reported) via intramuscularly on 04 October 2016 (also reported as over the past month). Patient's illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions was reported as unknown. On unspecified date (also reported as over the past month), following vaccination, the patient experienced small bruise, followed by triangular area of raised, red, and hot to touch. Entire area tender to touch, firmer skin at site. It was reported that the patient required emergency room or doctor visit. Lab data was not reported. Corrective treatment was reported as no. The outcome of the events was reported as unknown. List of documents held by sender: none.
Within fives minutes he began to cough, wheeze, watering eyes and eyelids swell. It progressed over the next 20 minutes to include a rash covering his entire body, hives scattered everywhere, hives on his eyelids, lips and his nose swelled and his ears were swollen and beat red. He went to the ER and was given Benadryl and observed until his O2 saturation got better.
I began experiencing a headache first around 10pm.  Then I got the chills around 11pm and had to put on multiple layers of clothing to be able to fall asleep.  I woke up around 10 am with muscle aches, still exhausted and nausea when I stayed on my feet for too long.  I slept again from 2pm to 6pm. I took two Tylenol before I went to bed at 10 pm and broke into a cold sweat.  On 4/16/2021 I woke up around 9am and I feel much better. A little headache, but I have energy and no muscle aches or chills.
Large area of erythema (10x20cm) and pain- persists 9 days after administration of vaccine.
Fever, Chills, dizziness, nausea, whole body aches, stomach bloating, burning eyes, and burning during urination.  Approximate vital readings on 24 May 07 at 1:45PM: 101.4 degrees F, 150/80 Blood Pressure (120/60 is norm for this person), Heart Rate 108 BPM
severe vertigo event; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The patient is the reporter's mother.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VERTIGO (non-serious), outcome "unknown", described as "severe vertigo event".  Course of the event: the patient  exactly 3 weeks after she got her shot, she was hit with severe vertigo for the first time in her life. She had never had vertigo before.  Follow-up (11Feb2022): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
renal mass; Diarrhea; Vomiting; Nausea; Abdominal pain; Right anterior chest pain; shortness of breath; This case was reported by a physician via call center representative and described the occurrence of renal mass in a 89-year-old male patient who received Herpes zoster (Shingrix) (batch number G72Z4, expiry date 13th March 2022) for prophylaxis.   The patient's past medical history included colon cancer. Concurrent medical conditions included pleural effusion (right plural effusion), renal mass, atrial fibrillation, renal anemia (anemia due to kidney disease), restrictive pulmonary disease, cardiac failure, renal disease (Stage 4 kidney disease) and monoclonal gammopathy.   On 24th July 2020, the patient received the 1st dose of Shingrix (intramuscular). On 27th July 2020, 3 days after receiving Shingrix, the patient experienced renal mass, diarrhea, vomiting, nausea, abdominal pain, chest pain and shortness of breath. The patient was treated with ondansetron (Zofran), acetylsalicylic acid (Aspirin) and glyceryl trinitrate (Nitroglycerin). On 28th July 2020, the outcome of the diarrhea, vomiting, nausea, abdominal pain, chest pain and shortness of breath were recovered/resolved. On an unknown date, the outcome of the renal mass was not recovered/not resolved.   It was unknown if the reporter considered the renal mass, diarrhea, vomiting, nausea, abdominal pain, chest pain and shortness of breath to be related to Shingrix.   Additional details were provided as follows: The patient history includes: restrictive lung disease, heart failure, stage 4 kidney disease, atrial fibrillation, colon cancer, monoclonal gammopathy, right plural effusion, and anti-coagulation therapy.  On the morning of 27th July 2020, the patient began to experienced shortness of breath, abdominal pain, nausea, vomiting, and diarrhea and by that evening the patient complained of right anterior chest pain and was transported via ambulance to the emergency room.  The patient was treated with IV fluids, 4mg Zofran, 325 mg Asprin, and Nitroglycerin tablet. EKG test performed results were normal for patient's medical history. CT scan performed of abdomen and pelvis, no findings. Contributing to abdominal pain, however subsequent finding showed a renal mass. The patient discharged home 2 hours after arrival and the shortness of breath, abdominal pain, nausea, vomiting, diarrhea and right anterior chest pain fully resolved.  The reporter consent to follow up.
Heart racing and pounding, dizziness, fatigue, nausea, vomiting.
Pt states arm sore when using, cannot lift anything, cannot move arm above head or behind back, pain when using her walker, (in arm vaccinated) no strength in arm.
heart was racing and she felt dizzy. upon evaluation from EMS medical care, they reported that it was not from the vaccine. Patient declined going to the hospital afterwards
developed a lump at the site of GARDASIL 9 injection; This spontaneous report was received from a pharmacist via company representative concerning to a male patient of unknown age.  The patient's concurrent conditions, medical history, and concomitant medications were not provided.   On approximately 15-MAY-2019 (reported as " about 3 weeks ago"), the patient was vaccinated with a dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prevent Human papillomavirus  (HPV).     On an unknown date in 2019 (reported as "on an unknown date after this"), the patient developed a lump at the site of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) injection (injection site mass). No treatment was given for the adverse event. It was reported that the patient went to see the pharmacist.   At the time of the report, the outcome of injection site mass was reported as not recovered.   The relationship between adverse event and suspect therapy were not provided.
Burning lips, 3 hours after shot, continues ; breast milk reduced 12 hours after shot; headache on and off
vaccine expired on 31-Aug-2021 and vaccine was administered on 07-Sep-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine expired on 31-Aug-2021 and vaccine was administered on 07-Sep-2021) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. Concurrent medical conditions included Fish allergy, Diabetes mellitus (No recent change in status of chronic condition.), Smoker (No recent change in status of chronic condition.), Hypertriglyceridemia (No recent change in status of chronic condition.), Depression (No recent change in status of chronic condition.) and GERD (No recent change in status of chronic condition.)Concomitant products included GLIPIZIDE, OMEPRAZOLE, FLUOXETINE, METFORMIN and PRAVASTATIN for an unknown indication.On 07-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine expired on 31-Aug-2021 and vaccine was administered on 07-Sep-2021). On 07-Sep-2021, EXPIRED PRODUCT ADMINISTERED (vaccine expired on 31-Aug-2021 and vaccine was administered on 07-Sep-2021) had resolved. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No concomitant medications information was reported.No acute illnesses at the time of vaccination and up to one month before.The patient had not been diagnosed with tested positive for COVID-19. There was no adverse reaction.There was no temperature excursion.
pt recv vax 10SEP96 & it was reported that the rxn began a few days p/inj;pt hosp w/an acute infectious process, fever, rash, very ill;hosp for 2-3 days then 2-3 days p/discharge devel marked weakness in the lower extremities;adm 6OCT96;
Wednesday evening, patient started to experience swelling at the injection site which has resolved. Patient continues with diarrhea, lethargy, and rash across face. When asked to explain rash on face, patient states "I cannot explain it, its hard to describe." No complaints of facial itching or swelling.
I'm a general contractor I went out of town to visit a friend and lost my voice. I went to the hospital and they prescribed me prednisone and sent me on my way. Went home a 1.5 days later and it got worse and completely lost my voice. I went to the hospital and the Dr. prescribed me Flonase, antibiotics and more prednisone.
Patient initially had rash and myalgias the day of his shot. CK in the ER was in the 200s, 9/7 CK 500 at PCP followup, 9/9 CK 2791 at hospital. No myalgias with the rising CK, no blood or myoglobinuria, no fevers. 5/5 strength in all extremities.
This spontaneous report as received from a female patient of unknown age. On an unknown date the patient was vaccinated with a dose of zoster vaccine live (manufacturer unknown). On an unknown date the patient experienced adverse event reaction to the vaccine. It was unknown if the patient sought medical attention. The outcome of adverse reaction to the vaccine was unknown. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of cardiac disorder (a little bit of complication with their heart/pretty horrendous heart episode) and discomfort (it was uncomfortable) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 010M20A and 013L20A) for COVID-19 immunization. The patient's past medical history included sickness (in Jan 2021 patient was pretty sick; thought it might be COVID-19; but by the time they tested, the result was negative). Concurrent medical conditions included asthma, diabetes and atrial fibrillation. On Jan 17, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 13, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced cardiac disorder (a little bit of complication with their heart/pretty horrendous heart episode) and discomfort (it was uncomfortable). At the time of the report, cardiac disorder (a little bit of complication with their heart/pretty horrendous heart episode) and discomfort (it was uncomfortable): resolving. Treatment medication included steroids, a Z-pack and antibiotics. Patient put on steroids from Jan 2021 till Feb 2021. No concomitant medication reported.
Red, tender, and indurated vaccination site that started the day of the vaccination and progressively worsened since vaccination date. Associated with axillary lymphadenopathy on affected side.
This spontaneous report as received from a pharmacist refers to a 72 years old female patient. The patient was vaccinated with dose ZOSTAVAX in DEC-2011 (Lot number and route unknown). No other co-suspects were reported. No concomitant medications were reported. In DEC-2012 the patient developed stomach upset, pain in chest area and rash since receiving ZOSTAVAX. No treatment information was reported. The outcome of stomach upset, rash and pain in chest area was reported as not recovered. The relatedness for stomach upset, pain in chest area and rash was not reported for ZOSTAVAX. Discrepant information: onset date was "last couple of days" but in the narrative it was reported since receiving ZOSTAVAX. Additional information has been requested.